Target Therapy

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/31

encourage image

There's no tags or description

Looks like no tags are added yet.

32 Terms

1
New cards

-overexpression of transmembrane human epidermal growth factor receptor protein(HER2) is seen in 25% to 30% of patients

Trastuzumab

2
New cards

Tyrosine kinase activity is mediated by ______ of signaling proteins

phosphorylation

3
New cards

-binds to HER2 sites
-inhibits proliferation of cells that overexpress the HER2 protein
-when bound to HER2 it blocks downstream signaling pathways
-induces antibody-dependent cytotoxicty
-prevents the release of HER2

Trastuzumab(Herceptin)

4
New cards

Adverse effects include:
-congestive heart failure
-infusion related fever and chills
-pulmonary toxicity
-headache

Trastuzumab(herceptin)

5
New cards

What extreme caution should be taken with trastuzumab?

patients with preexisting cardiac dysfunction

6
New cards

-genetically engineered against the CD20 antigen that is on the surface of normal and malignant B lymphocytes

Rituximab

7
New cards

The Fab region of _____ binds to the CD20 antigen on the B lymphocytes

rituximab

8
New cards

-induces complement dependent cytotoxicity(CDC) and antibody dependent cell mediated cytotoxicity(ADCC) of B cells

rituximab

9
New cards

Adverse effects of what drug?
-hypotension
-bronchospasm
-angioedema

rituximab

10
New cards

What should be treated with rituximab to prevent angioedema?

diphenhydramine and acetaminophen

11
New cards

-approved for metastatic colorectal cancer
-given with 5-FU
-stops vascular endothelial growth factor from forming new blood vessels

bevacizumab(Avastin)

12
New cards

-treats KAS mediated colorectal head and neck cancers

Cetuximab(Erbitux) and Panitumumab(Vectibix)

13
New cards

-targets the EGFR on the surface of cancer cells
-appearance of rash seen as a positive sign of therapy

Cetuximab(Erbitux) and Panitumumab(Vectibix)

14
New cards

-targets BCR-ABL gene translocation(Phil chromosome) abnormal tyrosine kinase

Imatinib, dasatinib, and nilotinib
-tyrosine kinase inhibitors

15
New cards

-targets BCR-ABL tyrosine kinase which is present in almost all(95%) Chronic Myelogenous Leukemia patients

imatinib

16
New cards

Adverse effects include:
-fluid retention
-QT prolongation

Imatinib

17
New cards

-BRAF mutation abnormal tyrosine kinase that is always "on"
-occurs in 50% of melanoma patients

BRAF inhibitors

18
New cards

What are the BRAF inhibitors?

-Vemurafenib
-Dabrafenib

19
New cards

Must be BRAF V600E or V600K mutation positive to use

Vemurafenib and Dabrafenib

20
New cards

-inhibits MEK, a cell signaling protein downstream from RAF

Trametinib and Cobimetinib
-MEK 1 and 2 inhibitors

21
New cards

-used in combination with BRAF inhibitors in patients with BRAF V600E or V600K mutation

MEK 1 and 2 inhibitors

22
New cards

Adverse effects include:
-hypertension
-HF
-hepatotoxicity
-skin rash
-NVD
-myelosuppression
-hand-food syndrome

Trametinib and Cobimetinib

23
New cards

What drugs cause new malignancies, such as squamous cell carcinoma and basal cell carcinoma and QT prolongation and photosensitivity?

Vemurafenib and Dabrafenib

24
New cards

-EGFR inhibitor
-used to treat non-small cell lung cancer and pancreatic cancer
-extensive metabolism in the liver

Erlotinib

25
New cards

-oral serine/threonine and TK inhibitor
-used to treat renal cell carcinoma

Sorafenib and Sunitinib

26
New cards

-block angiogenesis and kill abnormal cells in bone marrow
-need the REMS program that causes severe birth defects

lenalidmide and pomalidomide and Thalidomide
-immunomodulators

27
New cards

-PD-1 inhibitors that increase T-cell activation which helps recognize cancer cells as foreign or non-self
-activates the immune system(antitumor response)

Pembrolizumab

28
New cards

-a human MoAB that blocks cytotoxic T-lymph. antigen(CTLA-4)
-approved to treat metastatic melanoma
-acts as a negative regulator of T-cell function

ipilimumab

29
New cards

-enhanced T-cell stimulation, proliferation, and antitumor activity
-it can take 3 months or longer to see a response in patients with melanoma

Ipilimumab

30
New cards

Adverse effects of what drug?
-autoimmune inflammatory toxicities
-enterocolitis, diarrhea
-hepatitis
-dermatitis skin rash
-neuropathy

Ipilimumab

31
New cards

-anti-CTLA-4 human IgG1
-activating the immune response(antitumor response)
-used in metastatic melanoma as single agent or in combination with Nivolumab

Ipilimumab

32
New cards

-inhibit proteasomes which help to regulate intracellular protein homeostasis by inhibiting cell cycle progression and inducing apoptosis

Bortezomib and Carfilzomib